Literature DB >> 26415719

Fetal cardiovascular remodeling persists at 6 months in infants with intrauterine growth restriction.

M Cruz-Lemini1, F Crispi1, B Valenzuela-Alcaraz1, F Figueras1, M Sitges2, B Bijnens3, E Gratacós1.   

Abstract

OBJECTIVES: Intrauterine growth restriction is associated with increased cardiovascular risk later in life but the link between fetal disease and postnatal risk is not well-documented. We evaluated longitudinally the association between cardiovascular remodeling in small-for-gestational-age (SGA) fetuses and at 6 months of age.
METHODS: A cohort of 80 SGA fetuses (defined by estimated fetal and birth weights < 10(th) centile) delivered > 34 weeks' gestation was compared with 80 normally grown age-matched control fetuses, with follow-up at 6 months of corrected age (i.e. 6 months from estimated date of delivery according to first-trimester crown-rump length). Cardiovascular evaluation included a comprehensive echocardiographic assessment in both fetuses and infants and blood pressure and aortic intima-media thickness (aIMT) measurement in infants. Parameters were adjusted by linear regression analysis for gender, gestational age at delivery, pre-eclampsia, prenatal glucocorticoid exposure, Cesarean delivery, admission to neonatal intensive care unit and body surface area.
RESULTS: Both pre- and postnatally, when compared with controls, the SGA group showed a more globular cardiac shape (left sphericity index: controls 2.06 vs SGA 1.87 (P = 0.022) prenatally and 1.92 vs 1.67 (P = 0.007) postnatally), as well as signs of systolic longitudinal dysfunction (systolic annular peak velocity (S'): 7.2 vs 6.3 cm/s (P = 0.003) prenatally and 7.9 vs 6.4 cm/s (P < 0.001) postnatally; tricuspid annular plane systolic excursion: 7.2 vs 6.8 mm (P = 0.015) prenatally and 16.0 vs 14.2 mm (P < 0.001) postnatally) and diastolic dysfunction (left isovolumetric relaxation time: 46 vs 52 ms (P < 0.001) prenatally and 50 vs 57 ms (P = 0.034) postnatally). In addition, infants in the SGA group had increased mean blood pressure (mean: 61 vs 70 mmHg, P < 0.001) and maximum aIMT (0.57 vs 0.66 mm; P < 0.001).
CONCLUSIONS: Primary cardiovascular changes are already present in the SGA fetus and persist at 6 months of age. These data support prenatal cardiovascular remodeling as a mechanistic pathway of increased risk later in life in cases of SGA, regardless of Doppler abnormalities.
Copyright © 2015 ISUOG. Published by John Wiley & Sons Ltd. Copyright © 2015 ISUOG. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cardiovascular remodeling; cardiovascular risk; fetal echocardiography; fetal programming

Mesh:

Year:  2016        PMID: 26415719     DOI: 10.1002/uog.15767

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  19 in total

1.  Reshaping the Preterm Heart: Shifting Cardiac Renin-Angiotensin System Towards Cardioprotection in Rats Exposed to Neonatal High-Oxygen Stress.

Authors:  Mariane Bertagnolli; Daniela R Dartora; Pablo Lamata; Ernesto Zacur; Thuy-An Mai-Vo; Ying He; Léonie Beauchamp; Adam J Lewandowski; Anik Cloutier; Megan R Sutherland; Robson A S Santos; Anne Monique Nuyt
Journal:  Hypertension       Date:  2022-05-19       Impact factor: 9.897

2.  Soluble guanylate cyclase stimulation in late gestation does not mitigate asymmetric intrauterine growth restriction or cardiovascular risk induced by placental ischemia in the rat.

Authors:  Laura E Coats; Bhavisha A Bakrania; Daniel R Bamrick-Fernandez; Allison M Ariatti; Adam Z Rawls; Norma B Ojeda; Barbara T Alexander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-03-19       Impact factor: 4.733

Review 3.  Cardiac magnetic resonance imaging: insights into developmental programming and its consequences for aging.

Authors:  G D Clarke; J Li; A H Kuo; A J Moody; P W Nathanielsz
Journal:  J Dev Orig Health Dis       Date:  2020-12-22       Impact factor: 2.401

4.  Early characteristics of infants with pulmonary hypertension in a referral neonatal intensive care unit.

Authors:  Shilpa Vyas-Read; Usama Kanaan; Prabhu Shankar; Jane Stremming; Curtis Travers; David P Carlton; Anne Fitzpatrick
Journal:  BMC Pediatr       Date:  2017-07-11       Impact factor: 2.125

Review 5.  Intrauterine growth restriction - impact on cardiovascular diseases later in life.

Authors:  Carlos Menendez-Castro; Wolfgang Rascher; Andrea Hartner
Journal:  Mol Cell Pediatr       Date:  2018-03-20

Review 6.  Pregnancy: An Underutilized Window of Opportunity to Improve Long-term Maternal and Infant Health-An Appeal for Continuous Family Care and Interdisciplinary Communication.

Authors:  Birgit Arabin; Ahmet A Baschat
Journal:  Front Pediatr       Date:  2017-04-13       Impact factor: 3.418

7.  Prenatal Diagnosis of Right Dominant Heart in Fetuses: A Tertiary Center Experience over a 7-year Period.

Authors:  Juan Feng; Mei Zhu; Hao Liang; Qiao Li
Journal:  Chin Med J (Engl)       Date:  2017-03-05       Impact factor: 2.628

8.  Cardiac Measurements of Size and Shape in Fetuses With Absent or Reversed End-Diastolic Velocity of the Umbilical Artery and Perinatal Survival and Severe Growth Restriction Before 34 Weeks' Gestation.

Authors:  Greggory R DeVore; Percy Pacora Portella; Edgar Hernandez Andrade; Lami Yeo; Roberto Romero
Journal:  J Ultrasound Med       Date:  2020-10-30       Impact factor: 2.754

9.  Body Fatness and Cardiovascular Health in Newborn Infants.

Authors:  Hasthi U Dissanayake; Rowena L McMullan; Yang Kong; Ian D Caterson; David S Celermajer; Melinda Phang; Camille Raynes-Greenow; Jaimie W Polson; Adrienne Gordon; Michael R Skilton
Journal:  J Clin Med       Date:  2018-09-11       Impact factor: 4.241

10.  Assessment of myocardial performance index in late-onset fetal growth restriction.

Authors:  Tran Thao Nguyen Nguyen; Tomomi Kotani; Kenji Imai; Takafumi Ushida; Yoshinori Moriyama; Tomoko Kobayashi; Kaoru Niimi; Seiji Sumigama; Eiko Yamamoto; Van Duc Vo; Minh Tam Le; Lam Huong Le; Dac Nguyen Nguyen; Vu Quoc Huy Nguyen; Quang Vinh Truong; Ngoc Thanh Cao; Fumitaka Kikkawa
Journal:  Nagoya J Med Sci       Date:  2021-05       Impact factor: 1.131

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.